nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfadiazine—CYP2E1—liver cancer	0.736	1	CbGaD
Sulfadiazine—CYP2C8—Sorafenib—liver cancer	0.0566	0.426	CbGbCtD
Sulfadiazine—CYP2C9—Sorafenib—liver cancer	0.0395	0.297	CbGbCtD
Sulfadiazine—CYP3A4—Sorafenib—liver cancer	0.0229	0.173	CbGbCtD
Sulfadiazine—CYP3A4—Doxorubicin—liver cancer	0.0139	0.105	CbGbCtD
Sulfadiazine—Nephrotic syndrome—Sorafenib—liver cancer	0.00402	0.0542	CcSEcCtD
Sulfadiazine—Tubulointerstitial nephritis—Sorafenib—liver cancer	0.00254	0.0342	CcSEcCtD
Sulfadiazine—Skin necrosis—Epirubicin—liver cancer	0.00205	0.0277	CcSEcCtD
Sulfadiazine—Anuria—Epirubicin—liver cancer	0.00205	0.0277	CcSEcCtD
Sulfadiazine—Anuria—Doxorubicin—liver cancer	0.0019	0.0256	CcSEcCtD
Sulfadiazine—Skin necrosis—Doxorubicin—liver cancer	0.0019	0.0256	CcSEcCtD
Sulfadiazine—Skin exfoliation—Sorafenib—liver cancer	0.00185	0.025	CcSEcCtD
Sulfadiazine—Sulfamethoxazole—NAT2—liver cancer	0.00158	0.254	CrCbGaD
Sulfadiazine—Dermatitis exfoliative—Sorafenib—liver cancer	0.00149	0.0201	CcSEcCtD
Sulfadiazine—Toxic epidermal necrolysis—Sorafenib—liver cancer	0.00127	0.0171	CcSEcCtD
Sulfadiazine—Dapsone—NAT2—liver cancer	0.00123	0.199	CrCbGaD
Sulfadiazine—Pancreatitis—Sorafenib—liver cancer	0.0012	0.0161	CcSEcCtD
Sulfadiazine—Eruption—Epirubicin—liver cancer	0.00117	0.0157	CcSEcCtD
Sulfadiazine—Eruption—Doxorubicin—liver cancer	0.00108	0.0146	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Sorafenib—liver cancer	0.00108	0.0145	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Sorafenib—liver cancer	0.00107	0.0144	CcSEcCtD
Sulfadiazine—Stomatitis—Sorafenib—liver cancer	0.00106	0.0143	CcSEcCtD
Sulfadiazine—Burning sensation—Epirubicin—liver cancer	0.00103	0.0139	CcSEcCtD
Sulfadiazine—Neuritis—Epirubicin—liver cancer	0.000962	0.013	CcSEcCtD
Sulfadiazine—Burning sensation—Doxorubicin—liver cancer	0.000956	0.0129	CcSEcCtD
Sulfadiazine—Erythema multiforme—Sorafenib—liver cancer	0.000922	0.0124	CcSEcCtD
Sulfadiazine—Tinnitus—Sorafenib—liver cancer	0.00091	0.0123	CcSEcCtD
Sulfadiazine—Neuritis—Doxorubicin—liver cancer	0.00089	0.012	CcSEcCtD
Sulfadiazine—Blood disorder—Epirubicin—liver cancer	0.00086	0.0116	CcSEcCtD
Sulfadiazine—Sulfasalazine—PPARG—liver cancer	0.0008	0.129	CrCbGaD
Sulfadiazine—Blood disorder—Doxorubicin—liver cancer	0.000795	0.0107	CcSEcCtD
Sulfadiazine—Skin discolouration—Epirubicin—liver cancer	0.000795	0.0107	CcSEcCtD
Sulfadiazine—Oliguria—Epirubicin—liver cancer	0.000779	0.0105	CcSEcCtD
Sulfadiazine—Leukopenia—Sorafenib—liver cancer	0.00076	0.0102	CcSEcCtD
Sulfadiazine—Skin discolouration—Doxorubicin—liver cancer	0.000736	0.00991	CcSEcCtD
Sulfadiazine—Arthralgia—Sorafenib—liver cancer	0.000723	0.00975	CcSEcCtD
Sulfadiazine—Oliguria—Doxorubicin—liver cancer	0.000721	0.00972	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Sorafenib—liver cancer	0.000693	0.00934	CcSEcCtD
Sulfadiazine—Skin exfoliation—Epirubicin—liver cancer	0.000685	0.00924	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Sorafenib—liver cancer	0.000679	0.00915	CcSEcCtD
Sulfadiazine—Aplastic anaemia—Epirubicin—liver cancer	0.000674	0.00909	CcSEcCtD
Sulfadiazine—Anorexia—Sorafenib—liver cancer	0.000661	0.00891	CcSEcCtD
Sulfadiazine—Skin exfoliation—Doxorubicin—liver cancer	0.000634	0.00855	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000631	0.00851	CcSEcCtD
Sulfadiazine—Aplastic anaemia—Doxorubicin—liver cancer	0.000624	0.00841	CcSEcCtD
Sulfadiazine—Sepsis—Epirubicin—liver cancer	0.000623	0.0084	CcSEcCtD
Sulfadiazine—Decreased appetite—Sorafenib—liver cancer	0.000603	0.00812	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Sorafenib—liver cancer	0.000598	0.00807	CcSEcCtD
Sulfadiazine—Sulfamethazine—ALB—liver cancer	0.000586	0.0942	CrCbGaD
Sulfadiazine—Vascular purpura—Epirubicin—liver cancer	0.000583	0.00785	CcSEcCtD
Sulfadiazine—Sepsis—Doxorubicin—liver cancer	0.000576	0.00777	CcSEcCtD
Sulfadiazine—Sulfamerazine—ALB—liver cancer	0.000573	0.0921	CrCbGaD
Sulfadiazine—Gastrointestinal pain—Sorafenib—liver cancer	0.000567	0.00764	CcSEcCtD
Sulfadiazine—Dermatitis exfoliative—Epirubicin—liver cancer	0.000552	0.00745	CcSEcCtD
Sulfadiazine—Urticaria—Sorafenib—liver cancer	0.000551	0.00742	CcSEcCtD
Sulfadiazine—Abdominal pain—Sorafenib—liver cancer	0.000548	0.00739	CcSEcCtD
Sulfadiazine—Body temperature increased—Sorafenib—liver cancer	0.000548	0.00739	CcSEcCtD
Sulfadiazine—Purpura—Epirubicin—liver cancer	0.000541	0.00729	CcSEcCtD
Sulfadiazine—Vascular purpura—Doxorubicin—liver cancer	0.000539	0.00727	CcSEcCtD
Sulfadiazine—Anaphylactoid reaction—Epirubicin—liver cancer	0.000538	0.00726	CcSEcCtD
Sulfadiazine—Hypoglycaemia—Epirubicin—liver cancer	0.000534	0.0072	CcSEcCtD
Sulfadiazine—Dermatitis exfoliative—Doxorubicin—liver cancer	0.000511	0.00689	CcSEcCtD
Sulfadiazine—Hypersensitivity—Sorafenib—liver cancer	0.000511	0.00688	CcSEcCtD
Sulfadiazine—Purpura—Doxorubicin—liver cancer	0.0005	0.00674	CcSEcCtD
Sulfadiazine—Anaphylactoid reaction—Doxorubicin—liver cancer	0.000498	0.00672	CcSEcCtD
Sulfadiazine—Hypoglycaemia—Doxorubicin—liver cancer	0.000494	0.00666	CcSEcCtD
Sulfadiazine—Pruritus—Sorafenib—liver cancer	0.00049	0.00661	CcSEcCtD
Sulfadiazine—Ataxia—Epirubicin—liver cancer	0.00049	0.00661	CcSEcCtD
Sulfadiazine—Diarrhoea—Sorafenib—liver cancer	0.000474	0.00639	CcSEcCtD
Sulfadiazine—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.000469	0.00633	CcSEcCtD
Sulfadiazine—Ataxia—Doxorubicin—liver cancer	0.000453	0.00611	CcSEcCtD
Sulfadiazine—Sulfamethizole—ALB—liver cancer	0.000444	0.0714	CrCbGaD
Sulfadiazine—Pancreatitis—Epirubicin—liver cancer	0.000442	0.00595	CcSEcCtD
Sulfadiazine—Vomiting—Sorafenib—liver cancer	0.000441	0.00594	CcSEcCtD
Sulfadiazine—Rash—Sorafenib—liver cancer	0.000437	0.00589	CcSEcCtD
Sulfadiazine—Dermatitis—Sorafenib—liver cancer	0.000437	0.00589	CcSEcCtD
Sulfadiazine—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.000434	0.00585	CcSEcCtD
Sulfadiazine—Headache—Sorafenib—liver cancer	0.000434	0.00585	CcSEcCtD
Sulfadiazine—Nausea—Sorafenib—liver cancer	0.000412	0.00555	CcSEcCtD
Sulfadiazine—Pancreatitis—Doxorubicin—liver cancer	0.000409	0.00551	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000398	0.00537	CcSEcCtD
Sulfadiazine—Sulfanilamide—CYP2E1—liver cancer	0.000398	0.064	CrCbGaD
Sulfadiazine—Neuropathy peripheral—Epirubicin—liver cancer	0.000394	0.00531	CcSEcCtD
Sulfadiazine—Stomatitis—Epirubicin—liver cancer	0.000391	0.00528	CcSEcCtD
Sulfadiazine—Agranulocytosis—Epirubicin—liver cancer	0.000375	0.00505	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000368	0.00497	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Doxorubicin—liver cancer	0.000364	0.00491	CcSEcCtD
Sulfadiazine—Stomatitis—Doxorubicin—liver cancer	0.000362	0.00488	CcSEcCtD
Sulfadiazine—Hepatitis—Epirubicin—liver cancer	0.000361	0.00486	CcSEcCtD
Sulfadiazine—Dapsone—CYP2E1—liver cancer	0.000355	0.0571	CrCbGaD
Sulfadiazine—Agranulocytosis—Doxorubicin—liver cancer	0.000347	0.00467	CcSEcCtD
Sulfadiazine—Erythema multiforme—Epirubicin—liver cancer	0.000341	0.0046	CcSEcCtD
Sulfadiazine—Tinnitus—Epirubicin—liver cancer	0.000336	0.00453	CcSEcCtD
Sulfadiazine—Hepatitis—Doxorubicin—liver cancer	0.000334	0.0045	CcSEcCtD
Sulfadiazine—Chills—Epirubicin—liver cancer	0.000324	0.00436	CcSEcCtD
Sulfadiazine—Erythema multiforme—Doxorubicin—liver cancer	0.000315	0.00425	CcSEcCtD
Sulfadiazine—Tinnitus—Doxorubicin—liver cancer	0.000311	0.00419	CcSEcCtD
Sulfadiazine—Chills—Doxorubicin—liver cancer	0.000299	0.00403	CcSEcCtD
Sulfadiazine—Vertigo—Epirubicin—liver cancer	0.000282	0.0038	CcSEcCtD
Sulfadiazine—Leukopenia—Epirubicin—liver cancer	0.000281	0.00379	CcSEcCtD
Sulfadiazine—Convulsion—Epirubicin—liver cancer	0.000272	0.00367	CcSEcCtD
Sulfadiazine—Arthralgia—Epirubicin—liver cancer	0.000267	0.0036	CcSEcCtD
Sulfadiazine—Vertigo—Doxorubicin—liver cancer	0.000261	0.00352	CcSEcCtD
Sulfadiazine—Leukopenia—Doxorubicin—liver cancer	0.00026	0.0035	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Epirubicin—liver cancer	0.000256	0.00345	CcSEcCtD
Sulfadiazine—Convulsion—Doxorubicin—liver cancer	0.000252	0.00339	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Epirubicin—liver cancer	0.000251	0.00338	CcSEcCtD
Sulfadiazine—Sulfamethoxazole—ALB—liver cancer	0.000249	0.0401	CrCbGaD
Sulfadiazine—Arthralgia—Doxorubicin—liver cancer	0.000247	0.00333	CcSEcCtD
Sulfadiazine—Anorexia—Epirubicin—liver cancer	0.000244	0.00329	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Doxorubicin—liver cancer	0.000237	0.00319	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000233	0.00315	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Doxorubicin—liver cancer	0.000232	0.00313	CcSEcCtD
Sulfadiazine—Insomnia—Epirubicin—liver cancer	0.000232	0.00312	CcSEcCtD
Sulfadiazine—Anorexia—Doxorubicin—liver cancer	0.000226	0.00305	CcSEcCtD
Sulfadiazine—Decreased appetite—Epirubicin—liver cancer	0.000223	0.003	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Epirubicin—liver cancer	0.000221	0.00298	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000216	0.00291	CcSEcCtD
Sulfadiazine—Insomnia—Doxorubicin—liver cancer	0.000214	0.00289	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Epirubicin—liver cancer	0.000209	0.00282	CcSEcCtD
Sulfadiazine—Decreased appetite—Doxorubicin—liver cancer	0.000206	0.00278	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000205	0.00276	CcSEcCtD
Sulfadiazine—Urticaria—Epirubicin—liver cancer	0.000203	0.00274	CcSEcCtD
Sulfadiazine—Abdominal pain—Epirubicin—liver cancer	0.000202	0.00273	CcSEcCtD
Sulfadiazine—Body temperature increased—Epirubicin—liver cancer	0.000202	0.00273	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Doxorubicin—liver cancer	0.000194	0.00261	CcSEcCtD
Sulfadiazine—Hypersensitivity—Epirubicin—liver cancer	0.000189	0.00254	CcSEcCtD
Sulfadiazine—Urticaria—Doxorubicin—liver cancer	0.000188	0.00254	CcSEcCtD
Sulfadiazine—Abdominal pain—Doxorubicin—liver cancer	0.000187	0.00253	CcSEcCtD
Sulfadiazine—Body temperature increased—Doxorubicin—liver cancer	0.000187	0.00253	CcSEcCtD
Sulfadiazine—Pruritus—Epirubicin—liver cancer	0.000181	0.00244	CcSEcCtD
Sulfadiazine—Diarrhoea—Epirubicin—liver cancer	0.000175	0.00236	CcSEcCtD
Sulfadiazine—Hypersensitivity—Doxorubicin—liver cancer	0.000175	0.00235	CcSEcCtD
Sulfadiazine—CYP3A4—Biological oxidations—UGDH—liver cancer	0.000174	0.00343	CbGpPWpGaD
Sulfadiazine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000173	0.0034	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—GSTA4—liver cancer	0.000171	0.00336	CbGpPWpGaD
Sulfadiazine—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.00017	0.00335	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metapathway biotransformation—GSTA4—liver cancer	0.000168	0.00331	CbGpPWpGaD
Sulfadiazine—Pruritus—Doxorubicin—liver cancer	0.000168	0.00226	CcSEcCtD
Sulfadiazine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.000167	0.00329	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—GSTA2—liver cancer	0.000166	0.00327	CbGpPWpGaD
Sulfadiazine—Vomiting—Epirubicin—liver cancer	0.000163	0.0022	CcSEcCtD
Sulfadiazine—CYP2C9—Arachidonic acid metabolism—CYP1A1—liver cancer	0.000162	0.0032	CbGpPWpGaD
Sulfadiazine—Diarrhoea—Doxorubicin—liver cancer	0.000162	0.00219	CcSEcCtD
Sulfadiazine—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000162	0.00318	CbGpPWpGaD
Sulfadiazine—Rash—Epirubicin—liver cancer	0.000162	0.00218	CcSEcCtD
Sulfadiazine—Dermatitis—Epirubicin—liver cancer	0.000161	0.00218	CcSEcCtD
Sulfadiazine—Headache—Epirubicin—liver cancer	0.00016	0.00216	CcSEcCtD
Sulfadiazine—CYP2C8—Biological oxidations—GSTA1—liver cancer	0.00016	0.00316	CbGpPWpGaD
Sulfadiazine—CYP3A4—Tryptophan metabolism—CYP2E1—liver cancer	0.000159	0.00314	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—NAT2—liver cancer	0.000159	0.00312	CbGpPWpGaD
Sulfadiazine—CYP2C9—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.000158	0.00312	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metapathway biotransformation—NAT2—liver cancer	0.000156	0.00308	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—NR1H4—liver cancer	0.000154	0.00304	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metapathway biotransformation—GPX3—liver cancer	0.000154	0.00303	CbGpPWpGaD
Sulfadiazine—Nausea—Epirubicin—liver cancer	0.000152	0.00205	CcSEcCtD
Sulfadiazine—CYP2C9—Biological oxidations—GSTA3—liver cancer	0.000152	0.00299	CbGpPWpGaD
Sulfadiazine—Vomiting—Doxorubicin—liver cancer	0.000151	0.00203	CcSEcCtD
Sulfadiazine—CYP2C9—Metapathway biotransformation—GSTA3—liver cancer	0.00015	0.00295	CbGpPWpGaD
Sulfadiazine—Rash—Doxorubicin—liver cancer	0.000149	0.00201	CcSEcCtD
Sulfadiazine—Dermatitis—Doxorubicin—liver cancer	0.000149	0.00201	CcSEcCtD
Sulfadiazine—Headache—Doxorubicin—liver cancer	0.000148	0.002	CcSEcCtD
Sulfadiazine—CYP2E1—Biological oxidations—HPGDS—liver cancer	0.000147	0.00289	CbGpPWpGaD
Sulfadiazine—Nausea—Doxorubicin—liver cancer	0.000141	0.0019	CcSEcCtD
Sulfadiazine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.00014	0.00276	CbGpPWpGaD
Sulfadiazine—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.00014	0.00275	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—GSTA4—liver cancer	0.000139	0.00273	CbGpPWpGaD
Sulfadiazine—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000139	0.00273	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metapathway biotransformation—GSTA4—liver cancer	0.000137	0.0027	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—GSTA2—liver cancer	0.000135	0.00266	CbGpPWpGaD
Sulfadiazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	0.000133	0.00263	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metapathway biotransformation—GPX3—liver cancer	0.000133	0.00262	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—GSTA1—liver cancer	0.000131	0.00257	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—NAT2—liver cancer	0.000129	0.00254	CbGpPWpGaD
Sulfadiazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.000129	0.00254	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metapathway biotransformation—NAT2—liver cancer	0.000127	0.00251	CbGpPWpGaD
Sulfadiazine—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.000127	0.0025	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—HPGDS—liver cancer	0.000127	0.0025	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.000117	0.00231	CbGpPWpGaD
Sulfadiazine—CYP3A4—Tryptophan metabolism—CYP1A1—liver cancer	0.000115	0.00225	CbGpPWpGaD
Sulfadiazine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000114	0.00224	CbGpPWpGaD
Sulfadiazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.00011	0.00217	CbGpPWpGaD
Sulfadiazine—CYP2E1—Biological oxidations—GGT1—liver cancer	0.00011	0.00216	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metapathway biotransformation—GPX3—liver cancer	0.000108	0.00213	CbGpPWpGaD
Sulfadiazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.000104	0.00206	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—CYP2E1—liver cancer	0.000103	0.00204	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—HPGDS—liver cancer	0.000103	0.00203	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metapathway biotransformation—CYP2E1—liver cancer	0.000102	0.00201	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—NR1H4—liver cancer	0.000102	0.00201	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—GSTA3—liver cancer	0.0001	0.00197	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metapathway biotransformation—GSTA3—liver cancer	9.88e-05	0.00194	CbGpPWpGaD
Sulfadiazine—CYP2E1—Biological oxidations—GSTP1—liver cancer	9.87e-05	0.00194	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metapathway biotransformation—GSTP1—liver cancer	9.73e-05	0.00192	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—EPT1—liver cancer	9.55e-05	0.00188	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—GGT1—liver cancer	9.49e-05	0.00187	CbGpPWpGaD
Sulfadiazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	9.26e-05	0.00182	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—GSTA4—liver cancer	9.16e-05	0.0018	CbGpPWpGaD
Sulfadiazine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—liver cancer	9.14e-05	0.0018	CbGpPWpGaD
Sulfadiazine—CYP2E1—Biological oxidations—GSTM1—liver cancer	9.07e-05	0.00178	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metapathway biotransformation—GSTA4—liver cancer	9.03e-05	0.00178	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metapathway biotransformation—GSTM1—liver cancer	8.94e-05	0.00176	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—GSTA2—liver cancer	8.93e-05	0.00176	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—GSTA1—liver cancer	8.61e-05	0.0017	CbGpPWpGaD
Sulfadiazine—CYP2E1—Biological oxidations—CYP1A1—liver cancer	8.59e-05	0.00169	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—GSTP1—liver cancer	8.53e-05	0.00168	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—NAT2—liver cancer	8.52e-05	0.00168	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metapathway biotransformation—CYP1A1—liver cancer	8.48e-05	0.00167	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—CYP2E1—liver cancer	8.42e-05	0.00166	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metapathway biotransformation—GSTP1—liver cancer	8.41e-05	0.00166	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	8.4e-05	0.00165	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metapathway biotransformation—CYP2E1—liver cancer	8.3e-05	0.00163	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—GSTM1—liver cancer	7.84e-05	0.00154	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metapathway biotransformation—GSTM1—liver cancer	7.73e-05	0.00152	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—GGT1—liver cancer	7.73e-05	0.00152	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	7.56e-05	0.00149	CbGpPWpGaD
Sulfadiazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	7.51e-05	0.00148	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—CYP1A1—liver cancer	7.43e-05	0.00146	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metapathway biotransformation—CYP1A1—liver cancer	7.33e-05	0.00144	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	7.29e-05	0.00143	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	7.14e-05	0.00141	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—GSTP1—liver cancer	6.94e-05	0.00137	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metapathway biotransformation—GSTP1—liver cancer	6.85e-05	0.00135	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—HPGDS—liver cancer	6.81e-05	0.00134	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—UGDH—liver cancer	6.43e-05	0.00127	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—GSTM1—liver cancer	6.38e-05	0.00126	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metapathway biotransformation—GSTM1—liver cancer	6.29e-05	0.00124	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	6.15e-05	0.00121	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—CYP1A1—liver cancer	6.05e-05	0.00119	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—EPT1—liver cancer	6.04e-05	0.00119	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metapathway biotransformation—CYP1A1—liver cancer	5.96e-05	0.00117	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	5.93e-05	0.00117	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—TAT—liver cancer	5.73e-05	0.00113	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	5.57e-05	0.0011	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—UGDH—liver cancer	5.56e-05	0.00109	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—CYP2E1—liver cancer	5.55e-05	0.00109	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	5.47e-05	0.00108	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—EPT1—liver cancer	5.22e-05	0.00103	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—GGT1—liver cancer	5.1e-05	0.001	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—TAT—liver cancer	4.95e-05	0.000975	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	4.87e-05	0.000959	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—GSTP1—liver cancer	4.58e-05	0.000901	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	4.54e-05	0.000893	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—UGDH—liver cancer	4.52e-05	0.00089	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	4.51e-05	0.000889	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—EPT1—liver cancer	4.25e-05	0.000837	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—GSTM1—liver cancer	4.21e-05	0.000828	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	4.15e-05	0.000817	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—TAT—liver cancer	4.03e-05	0.000793	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—CYP1A1—liver cancer	3.99e-05	0.000785	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	3.96e-05	0.00078	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	3.93e-05	0.000774	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CPT1B—liver cancer	3.89e-05	0.000767	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GLUL—liver cancer	3.89e-05	0.000767	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—NR1H4—liver cancer	3.76e-05	0.000739	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GSTA3—liver cancer	3.69e-05	0.000727	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—liver cancer	3.65e-05	0.000718	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GSTA4—liver cancer	3.38e-05	0.000665	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CPT1B—liver cancer	3.37e-05	0.000663	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GLUL—liver cancer	3.37e-05	0.000663	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GSTA2—liver cancer	3.29e-05	0.000648	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—NR1H4—liver cancer	3.25e-05	0.000639	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GSTA3—liver cancer	3.19e-05	0.000628	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GSTA1—liver cancer	3.17e-05	0.000625	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—NAT2—liver cancer	3.14e-05	0.000618	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ALDOB—liver cancer	3.01e-05	0.000592	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—UGDH—liver cancer	2.98e-05	0.000587	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—liver cancer	2.97e-05	0.000584	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GSTA4—liver cancer	2.92e-05	0.000575	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CRABP1—liver cancer	2.87e-05	0.000565	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	2.85e-05	0.000562	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GSTA2—liver cancer	2.84e-05	0.00056	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—EPT1—liver cancer	2.8e-05	0.000552	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GSTA1—liver cancer	2.74e-05	0.00054	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CPT1B—liver cancer	2.74e-05	0.000539	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GLUL—liver cancer	2.74e-05	0.000539	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—NAT2—liver cancer	2.71e-05	0.000534	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—TAT—liver cancer	2.66e-05	0.000523	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—NR1H4—liver cancer	2.64e-05	0.00052	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.61e-05	0.000514	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ALDOB—liver cancer	2.6e-05	0.000512	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GSTA3—liver cancer	2.6e-05	0.000511	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—HPGDS—liver cancer	2.51e-05	0.000494	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CRABP1—liver cancer	2.48e-05	0.000489	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GSTA4—liver cancer	2.38e-05	0.000468	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	2.32e-05	0.000457	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GSTA2—liver cancer	2.31e-05	0.000456	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PSMD10—liver cancer	2.24e-05	0.00044	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PSMA4—liver cancer	2.24e-05	0.00044	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.23e-05	0.00044	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GSTA1—liver cancer	2.23e-05	0.00044	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—NAT2—liver cancer	2.21e-05	0.000435	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GOT2—liver cancer	2.18e-05	0.000428	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—HPGDS—liver cancer	2.17e-05	0.000427	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.16e-05	0.000425	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.12e-05	0.000418	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ALDOB—liver cancer	2.12e-05	0.000417	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CRABP1—liver cancer	2.02e-05	0.000398	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.96e-05	0.000387	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.94e-05	0.000382	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PSMA4—liver cancer	1.93e-05	0.000381	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PSMD10—liver cancer	1.93e-05	0.000381	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CYCS—liver cancer	1.91e-05	0.000377	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GOT2—liver cancer	1.88e-05	0.00037	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GOT1—liver cancer	1.88e-05	0.00037	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GGT1—liver cancer	1.88e-05	0.00037	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.82e-05	0.000358	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GLUL—liver cancer	1.81e-05	0.000356	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CPT1B—liver cancer	1.81e-05	0.000356	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CYP2E1—liver cancer	1.77e-05	0.000348	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—HPGDS—liver cancer	1.77e-05	0.000348	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.76e-05	0.000345	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—NR1H4—liver cancer	1.74e-05	0.000343	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GSTA3—liver cancer	1.71e-05	0.000337	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.71e-05	0.000337	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GSTP1—liver cancer	1.69e-05	0.000332	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—HMOX1—liver cancer	1.66e-05	0.000328	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CYCS—liver cancer	1.65e-05	0.000326	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GGT1—liver cancer	1.62e-05	0.00032	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GOT1—liver cancer	1.62e-05	0.00032	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.6e-05	0.000315	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.58e-05	0.000311	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PSMA4—liver cancer	1.57e-05	0.00031	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PSMD10—liver cancer	1.57e-05	0.00031	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GSTA4—liver cancer	1.57e-05	0.000308	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GSTM1—liver cancer	1.55e-05	0.000305	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GOT2—liver cancer	1.53e-05	0.000301	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GSTA2—liver cancer	1.53e-05	0.000301	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GSTA1—liver cancer	1.47e-05	0.00029	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CYP1A1—liver cancer	1.47e-05	0.000289	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GSTP1—liver cancer	1.46e-05	0.000287	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—NAT2—liver cancer	1.46e-05	0.000287	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CYP2E1—liver cancer	1.44e-05	0.000283	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—HMOX1—liver cancer	1.44e-05	0.000283	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ALDOB—liver cancer	1.4e-05	0.000275	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.39e-05	0.000274	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—MTHFR—liver cancer	1.37e-05	0.00027	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CYCS—liver cancer	1.35e-05	0.000265	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PPARA—liver cancer	1.34e-05	0.000265	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GSTM1—liver cancer	1.34e-05	0.000264	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CRABP1—liver cancer	1.33e-05	0.000262	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GGT1—liver cancer	1.32e-05	0.00026	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GOT1—liver cancer	1.32e-05	0.00026	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CYP1A1—liver cancer	1.27e-05	0.00025	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GSTP1—liver cancer	1.19e-05	0.000234	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—MTHFR—liver cancer	1.18e-05	0.000233	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—HMOX1—liver cancer	1.17e-05	0.00023	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—HPGDS—liver cancer	1.16e-05	0.000229	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PPARA—liver cancer	1.16e-05	0.000229	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PIK3CG—liver cancer	1.15e-05	0.000227	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PPARG—liver cancer	1.11e-05	0.000219	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GSTM1—liver cancer	1.09e-05	0.000215	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.04e-05	0.000205	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PSMD10—liver cancer	1.04e-05	0.000204	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PSMA4—liver cancer	1.04e-05	0.000204	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CYP1A1—liver cancer	1.03e-05	0.000204	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PIK3CD—liver cancer	1.01e-05	0.000199	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GOT2—liver cancer	1.01e-05	0.000199	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ALB—liver cancer	9.99e-06	0.000197	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PIK3CG—liver cancer	9.95e-06	0.000196	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—MTHFR—liver cancer	9.64e-06	0.00019	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PPARG—liver cancer	9.6e-06	0.000189	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CYP2E1—liver cancer	9.49e-06	0.000187	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PPARA—liver cancer	9.46e-06	0.000186	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CYCS—liver cancer	8.88e-06	0.000175	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PIK3CB—liver cancer	8.82e-06	0.000174	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PIK3CD—liver cancer	8.75e-06	0.000172	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GGT1—liver cancer	8.71e-06	0.000172	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GOT1—liver cancer	8.71e-06	0.000172	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ALB—liver cancer	8.64e-06	0.00017	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	8.49e-06	0.000167	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PIK3CG—liver cancer	8.1e-06	0.000159	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GSTP1—liver cancer	7.83e-06	0.000154	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PPARG—liver cancer	7.82e-06	0.000154	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—HMOX1—liver cancer	7.72e-06	0.000152	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PIK3CB—liver cancer	7.63e-06	0.00015	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GSTM1—liver cancer	7.19e-06	0.000142	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PIK3CD—liver cancer	7.12e-06	0.00014	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ALB—liver cancer	7.03e-06	0.000138	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CYP1A1—liver cancer	6.82e-06	0.000134	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—MTHFR—liver cancer	6.36e-06	0.000125	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PPARA—liver cancer	6.24e-06	0.000123	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PIK3CB—liver cancer	6.21e-06	0.000122	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PIK3CA—liver cancer	5.38e-06	0.000106	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PIK3CG—liver cancer	5.34e-06	0.000105	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PPARG—liver cancer	5.16e-06	0.000101	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PIK3CD—liver cancer	4.7e-06	9.24e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PIK3CA—liver cancer	4.65e-06	9.15e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ALB—liver cancer	4.64e-06	9.12e-05	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—AKT1—liver cancer	4.39e-06	8.65e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PIK3CB—liver cancer	4.09e-06	8.06e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—AKT1—liver cancer	3.8e-06	7.47e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PIK3CA—liver cancer	3.78e-06	7.45e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—AKT1—liver cancer	3.09e-06	6.08e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PIK3CA—liver cancer	2.49e-06	4.91e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—AKT1—liver cancer	2.04e-06	4.01e-05	CbGpPWpGaD
